Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 3 3Phase 2 2Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Breast 4Other 3Thoracic 2Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Gynecologic 2CNS 2Sarcoma 1Myeloid 1

Conditions

Ovarian Neoplasms 805Uterine Cervical Neoplasms 409Fallopian Tube Neoplasms 289Endometrial Neoplasms 287Carcinoma, Ovarian Epithelial 252Neoplasms 95Recurrence 83Breast Neoplasms 82Peritoneal Neoplasms 66Uterine Neoplasms 55Colorectal Neoplasms 54Uterine Cervical Dysplasia 50Sarcoma 49Vulvar Neoplasms 47Neoplasm Metastasis 44Carcinoma, Non-Small-Cell Lung 44Stomach Neoplasms 42Pancreatic Neoplasms 36Melanoma 34Testicular Neoplasms 32Lung Neoplasms 32Vaginal Neoplasms 28Prostatic Neoplasms 28Papillomavirus Infections 25Carcinoma 25Head and Neck Neoplasms 23Esophageal Neoplasms 23Carcinoma, Renal Cell 23Urinary Bladder Neoplasms 21Small Cell Lung Carcinoma 21

Interventions

yangzheng xiaoji 1niraparib 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Nausea × Gynecologic × Clear all
NCT05641506 2022-12-07

A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
50 enrolled
Gynecologic

Nausea, Ovarian Neoplasms

NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Northwestern University

Phase 2 Completed
GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡